EDGAR Filing Documents for 0001193125-17-321203

Form 8-K - Current report:

SEC Accession No. 0001193125-17-321203

Filing Date

2017-10-26

Accepted

2017-10-26 16:04:06

Documents

Period of Report

2017-10-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d477955d8k.htm	8-K	30729
2	EX-1.1	d477955dex11.htm	EX-1.1	198426
3	EX-1.2	d477955dex12.htm	EX-1.2	199350
4	EX-3.1	d477955dex31.htm	EX-3.1	77435
5	EX-4.1	d477955dex41.htm	EX-4.1	6187
6	EX-4.2	d477955dex42.htm	EX-4.2	75177
7	EX-5.1	d477955dex51.htm	EX-5.1	16318
8	GRAPHIC	g477955g81g56.jpg	GRAPHIC	2953
	Complete submission text file	0001193125-17-321203.txt		609342

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)